Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Cinchocaine | hsa00030 | Pentose phosphate pathway | 1.95E-02 | 3 | P51854, P08237, P37837 | TKTL1, PFKM, TALDO1 | More | | Cinchocaine | hsa00230 | Purine metabolism | 4.60E-02 | 4 | Q13370, P36959, Q13956, P27707 | PDE3B, GMPR, PDE6H, DCK | More | | Cinchocaine | hsa00240 | Pyrimidine metabolism | 4.50E-02 | 2 | P32320, P27707 | CDA, DCK | More | | Cinchocaine | hsa00310 | Lysine degradation | 2.59E-02 | 2 | Q96KQ7, P51648 | EHMT2, ALDH3A2 | More | | Cinchocaine | hsa00512 | Mucin type O-glycan biosynthesis | 3.19E-03 | 3 | O95395, Q8N4A0, Q9NY28 | GCNT3, GALNT4, GALNT8 | More | | Cinchocaine | hsa00534 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin | 4.77E-02 | 1 | Q7LGA3 | HS2ST1 | More | | Cinchocaine | hsa00630 | Glyoxylate and dicarboxylate metabolism | 9.21E-03 | 2 | P40925, P15104 | MDH1, GLUL | More | | Cinchocaine | hsa00670 | One carbon pool by folate | 3.99E-02 | 2 | O95954, Q99707 | FTCD, MTR | More | | Cinchocaine | hsa00760 | Nicotinate and nicotinamide metabolism | 3.52E-02 | 1 | P21589 | NT5E | More | | Cinchocaine | hsa00770 | Pantothenate and CoA biosynthesis | 1.15E-02 | 2 | O95498, Q9NRN7 | VNN2, AASDHPPT | More | | Cinchocaine | hsa00920 | Sulfur metabolism | 3.01E-02 | 1 | O95571 | ETHE1 | More | | Cinchocaine | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.78E-02 | 2 | O95363, Q15046 | FARS2, KARS | More | | Cinchocaine | hsa00983 | Drug metabolism - other enzymes | 3.59E-02 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Cinchocaine | hsa01100 | Metabolic pathways | 1.58E-03 | 50 | Q9Y234, P35790, Q16772, P15144, P30041, Q99707, P29218, O14732, P11310, P27707, Q13370, P36959, Q13956, Q02153, Q16774, P20839, P00918, P10768, P55809, P06280, P30043, Q9Y6K0, P08237, Q02252, P21399, O60701, O14772, O95954, Q02318, Q9UHK6, P51854, P04406, Q86VZ5, Q9BVK2, P15907, O96024, O15466, P09960, P37837, P50213, Q9P2R7, Q9UHY7, P43490, P35573, Q969G6, Q13488, Q16718, Q13029, Q9NVH6, Q02809 | LIPT1, CHKA, GSTA3, ANPEP, PRDX6, MTR, IMPA1, IMPA2, ACADM, DCK, PDE3B, GMPR, PDE6H, GUCY1B3, GUK1, IMPDH1, CA2, ESD, OXCT1, GLA, BLVRB, CEPT1, PFKM, ALDH6A1, ACO1, UGDH, FPGT, FTCD, CYP27A1, AMACR, TKTL1, GAPDH, SGMS1, ALG8, ST6GAL1, B3GALT4, ST8SIA5, LTA4H, TALDO1, IDH3A, SUCLA2, ENOPH1, PBEF1, AGL, RFK, TCIRG1, NDUFA5, PRDM2, TMLHE, PLOD1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q9Y234 | LIPT1 | Lipoyltransferase 1, mitochondrial | 0.778 | O15182 | CETN3 | Centrin-3 | Q9Y234 | LIPT1 | Lipoyltransferase 1, mitochondrial | 0.727 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P35790 | CHKA | Choline kinase alpha | -0.856 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q16772 | GSTA3 | Glutathione S-transferase A3 | -0.768 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P15144 | ANPEP | Aminopeptidase N | 0.846 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P30041 | PRDX6 | Peroxiredoxin-6 | 0.785 | O15182 | CETN3 | Centrin-3 | Q99707 | MTR | Methionine synthase | 0.924 | O15182 | CETN3 | Centrin-3 | P29218 | IMPA1 | Inositol monophosphatase 1 | 0.739 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | O14732 | IMPA2 | Inositol monophosphatase 2 | 0.738 | O15182 | CETN3 | Centrin-3 | P11310 | ACADM | Medium-chain specific acyl-CoA dehydrogenase, mitochondrial | 0.881 | O15182 | CETN3 | Centrin-3 | P27707 | DCK | Deoxycytidine kinase | 0.937 | O15182 | CETN3 | Centrin-3 | Q13370 | PDE3B | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0.707 | O15182 | CETN3 | Centrin-3 | P36959 | GMPR | GMP reductase 1 | -0.724 | O15182 | CETN3 | Centrin-3 | Q13956 | PDE6H | Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma | 0.857 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q02153 | GUCY1B3 | Guanylate cyclase soluble subunit beta-1 | -0.774 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q16774 | GUK1 | Guanylate kinase | 0.757 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | 1 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P00918 | CA2 | Carbonic anhydrase 2 | 0.772 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P10768 | ESD | S-formylglutathione hydrolase | -0.701 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.744 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P06280 | GLA | Alpha-galactosidase A | 0.728 | O15182 | CETN3 | Centrin-3 | P30043 | BLVRB | Flavin reductase | -0.859 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q9Y6K0 | CEPT1 | Choline/ethanolaminephosphotransferase 1 | 0.771 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P08237 | PFKM | ATP-dependent 6-phosphofructokinase, muscle type | 0.868 | O15182 | CETN3 | Centrin-3 | Q02252 | ALDH6A1 | Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial | 0.801 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P21399 | ACO1 | Cytoplasmic aconitate hydratase | -0.739 | O15182 | CETN3 | Centrin-3 | O60701 | UGDH | UDP-glucose 6-dehydrogenase | 0.717 | O15182 | CETN3 | Centrin-3 | O14772 | FPGT | Fucose-1-phosphate guanylyltransferase | 0.862 | O15182 | CETN3 | Centrin-3 | O95954 | FTCD | Formimidoyltransferase-cyclodeaminase | -0.706 | O15182 | CETN3 | Centrin-3 | Q02318 | CYP27A1 | Sterol 26-hydroxylase, mitochondrial | -0.805 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.784 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P51854 | TKTL1 | Transketolase-like protein 1 | -0.753 | O15182 | CETN3 | Centrin-3 | P04406 | GAPDH | Glyceraldehyde-3-phosphate dehydrogenase | -0.765 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.81 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q9BVK2 | ALG8 | Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase | -0.726 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P15907 | ST6GAL1 | Beta-galactoside alpha-2,6-sialyltransferase 1 | -0.827 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | O96024 | B3GALT4 | Beta-1,3-galactosyltransferase 4 | 0.797 | O15182 | CETN3 | Centrin-3 | O15466 | ST8SIA5 | Alpha-2,8-sialyltransferase 8E | -0.748 | O15182 | CETN3 | Centrin-3 | P09960 | LTA4H | Leukotriene A-4 hydrolase | -0.728 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P37837 | TALDO1 | Transaldolase | 0.732 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P50213 | IDH3A | Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial | -0.732 | O15182 | CETN3 | Centrin-3 | Q9P2R7 | SUCLA2 | Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial | 0.84 | O15182 | CETN3 | Centrin-3 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | 0.707 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.702 | O15182 | CETN3 | Centrin-3 | P35573 | AGL | Glycogen debranching enzyme | 0.749 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q969G6 | RFK | Riboflavin kinase | 0.705 | O15182 | CETN3 | Centrin-3 | Q13488 | TCIRG1 | V-type proton ATPase 116 kDa subunit a 3 | -0.767 | O15182 | CETN3 | Centrin-3 | Q16718 | NDUFA5 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5 | 0.785 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q13029 | PRDM2 | PR domain zinc finger protein 2 | 0.744 | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | Q9NVH6 | TMLHE | Trimethyllysine dioxygenase, mitochondrial | -0.721 | O15182 | CETN3 | Centrin-3 | Q02809 | PLOD1 | Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 | -0.849 |
| Cinchocaine | hsa01200 | Carbon metabolism | 1.81E-02 | 6 | P51854, P08237, P37837, P50213, P21399, P10768 | TKTL1, PFKM, TALDO1, IDH3A, ACO1, ESD | More | | Cinchocaine | hsa01210 | 2-Oxocarboxylic acid metabolism | 1.73E-02 | 2 | P21399, P50213 | ACO1, IDH3A | More | | Cinchocaine | hsa01230 | Biosynthesis of amino acids | 7.71E-03 | 5 | P08237, P51854, P21399, P50213, P37837 | PFKM, TKTL1, ACO1, IDH3A, TALDO1 | More | | Cinchocaine | hsa01524 | Platinum drug resistance | 4.45E-02 | 4 | P10415, Q13489, P78417, P43246 | BCL2, BIRC3, GSTO1, MSH2 | More | | Cinchocaine | hsa02010 | ABC transporters | 4.89E-02 | 1 | Q99758 | ABCA3 | More | | Cinchocaine | hsa03008 | Ribosome biogenesis in eukaryotes | 1.46E-02 | 4 | Q9NYH9, P78345, Q9BVP2, Q9GZY0 | UTP6, RPP38, GNL3, NXF2; NXF2B | More | | Cinchocaine | hsa03010 | Ribosome | 1.88E-02 | 6 | P62753, P25398, P32969, P62829, P18077, P36578 | RPS6, RPS12, RPL9, RPL23, RPL35A, RPL4 | More | | Cinchocaine | hsa03013 | RNA transport | 8.03E-03 | 10 | P62826, P52298, P61326, Q9GZY0, P63279, Q14152, O75822, P78345, Q9Y6A5, Q53GS7 | RAN, NCBP2, MAGOH, NXF2; NXF2B, UBE2I, EIF3A, EIF3J, RPP38, TACC3, GLE1 | More | | Cinchocaine | hsa03015 | mRNA surveillance pathway | 1.09E-03 | 6 | O43148, Q16537, P61326, Q9GZY0, P52298, Q53GS7 | RNMT, PPP2R5E, MAGOH, NXF2; NXF2B, NCBP2, GLE1 | More | | Cinchocaine | hsa03020 | RNA polymerase | 3.59E-02 | 2 | P30876, P62487 | POLR2B, POLR2G | More | | Cinchocaine | hsa03040 | Spliceosome | 7.93E-13 | 23 | Q14562, O43143, O60508, P17844, O14776, P08579, P26368, O75940, P52298, P09651, Q15365, O75494, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O95777, O43447, O75643, P61326 | DHX8, DHX15, CDC40, DDX5, TCERG1, SNRPB2, U2AF2, SMNDC1, NCBP2, HNRNPA1, PCBP1, FUSIP1, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, LSM8, PPIH, ASCC3L1, MAGOH | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P0DP23 | CALM1 | Calmodulin-1 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.942 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.775 | P0DP25 | CALM3 | Calmodulin-3 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.942 | P0DP24 | CALM2 | Calmodulin-2 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.942 | P0DP23 | CALM1 | Calmodulin-1 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.963 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.871 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.76 | P0DP25 | CALM3 | Calmodulin-3 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.963 | P0DP24 | CALM2 | Calmodulin-2 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.963 | P0DP23 | CALM1 | Calmodulin-1 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.828 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.716 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.812 | P0DP25 | CALM3 | Calmodulin-3 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.828 | P0DP24 | CALM2 | Calmodulin-2 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.828 | P0DP24 | CALM2 | Calmodulin-2 | P17844 | DDX5 | Probable ATP-dependent RNA helicase DDX5 | 0.734 | O15182 | CETN3 | Centrin-3 | O14776 | TCERG1 | Transcription elongation regulator 1 | 0.758 | P0DP23 | CALM1 | Calmodulin-1 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.781 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.822 | P0DP25 | CALM3 | Calmodulin-3 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.781 | P0DP24 | CALM2 | Calmodulin-2 | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | 0.781 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.751 | O15182 | CETN3 | Centrin-3 | O75940 | SMNDC1 | Survival of motor neuron-related-splicing factor 30 | 0.859 | O15182 | CETN3 | Centrin-3 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.701 | O15182 | CETN3 | Centrin-3 | P09651 | HNRNPA1 | Heterogeneous nuclear ribonucleoprotein A1 | 0.757 | P0DP24 | CALM2 | Calmodulin-2 | Q15365 | PCBP1 | Poly(rC)-binding protein 1 | 0.75 | O15182 | CETN3 | Centrin-3 | O75494 | FUSIP1 | Serine/arginine-rich splicing factor 10 | 0.85 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.74 | P0DP23 | CALM1 | Calmodulin-1 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.914 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.827 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.749 | P0DP25 | CALM3 | Calmodulin-3 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.914 | P0DP24 | CALM2 | Calmodulin-2 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.914 | P0DP23 | CALM1 | Calmodulin-1 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.841 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.783 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.798 | P0DP25 | CALM3 | Calmodulin-3 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.841 | P0DP24 | CALM2 | Calmodulin-2 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.841 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.773 | P0DP23 | CALM1 | Calmodulin-1 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.784 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.943 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.822 | P0DP25 | CALM3 | Calmodulin-3 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.784 | P0DP24 | CALM2 | Calmodulin-2 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.784 | P0DP23 | CALM1 | Calmodulin-1 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.804 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.876 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.802 | P0DP25 | CALM3 | Calmodulin-3 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.804 | P0DP24 | CALM2 | Calmodulin-2 | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.804 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.743 | O15182 | CETN3 | Centrin-3 | O95777 | LSM8 | U6 snRNA-associated Sm-like protein LSm8 | 0.723 | P0DP23 | CALM1 | Calmodulin-1 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | 0.748 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.766 | P0DP25 | CALM3 | Calmodulin-3 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | 0.748 | P0DP24 | CALM2 | Calmodulin-2 | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | 0.748 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.745 | O15182 | CETN3 | Centrin-3 | P61326 | MAGOH | Protein mago nashi homolog | 0.811 |
| Cinchocaine | hsa03050 | Proteasome | 5.53E-03 | 2 | P43686, P28070 | PSMC4, PSMB4 | More | | Cinchocaine | hsa03320 | PPAR signaling pathway | 2.18E-02 | 2 | O00767, Q02318 | SCD, CYP27A1 | More | | Cinchocaine | hsa03460 | Fanconi anemia pathway | 3.70E-03 | 3 | Q9NPI8, O60673, Q9UNA4 | FANCF, REV3L, POLI | More | | Cinchocaine | hsa04014 | Ras signaling pathway | 9.15E-06 | 14 | P31751, P42338, P20827, Q9NRA1, P49767, Q13009, P17252, Q15311, Q7LDG7, P0DP23, P62873, P63218, P50151, P19174 | AKT2, PIK3CB, EFNA1, PDGFC, VEGFC, TIAM1, PRKCA, RALBP1, RASGRP2, CALM1, GNB1, GNG5, GNG10, PLCG1 | More | | Cinchocaine | hsa04015 | Rap1 signaling pathway | 3.54E-04 | 13 | P20827, P49767, Q96FS4, P11215, Q13009, Q7LDG7, Q08828, P51828, P42338, P31751, P0DP23, P17252, P19174 | EFNA1, VEGFC, SIPA1, ITGAM, TIAM1, RASGRP2, ADCY1, ADCY7, PIK3CB, AKT2, CALM1, PRKCA, PLCG1 | More | | Cinchocaine | hsa04020 | Calcium signaling pathway | 1.04E-06 | 11 | P27987, Q08828, Q13557, P17252, O15399, P19174, P61073, P0DP23, P51828, P23634, P49767 | ITPKB, ADCY1, CAMK2D, PRKCA, GRIN2D, PLCG1, CXCR4, CALM1, ADCY7, ATP2B4, VEGFC | More | | Cinchocaine | hsa04024 | cAMP signaling pathway | 3.01E-03 | 9 | Q08828, P51828, P31751, P0DP23, P23634, Q13557, Q13370, O15399, Q13009 | ADCY1, ADCY7, AKT2, CALM1, ATP2B4, CAMK2D, PDE3B, GRIN2D, TIAM1 | More | | Cinchocaine | hsa04060 | Cytokine-cytokine receptor interaction | 4.71E-02 | 2 | P78552, O75509 | IL13RA1, TNFRSF21 | More | | Cinchocaine | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 4.48E-02 | 5 | P09341, P19875, P25024, P25025, P14784 | CXCL1, CXCL2, CXCR1, CXCR2, IL2RB | More | | Cinchocaine | hsa04062 | Chemokine signaling pathway | 5.18E-07 | 23 | P51684, P25024, P25025, P09341, P19875, Q8NHW4, P09769, P07948, P42338, P19174, P62873, P63218, P50151, P43250, Q08828, P51828, Q7LDG7, Q13009, P14598, P42224, P31751, P25963, Q8WYR1 | CCR6, CXCR1, CXCR2, CXCL1, CXCL2, CCL4L2, FGR, LYN, PIK3CB, PLCG1, GNB1, GNG5, GNG10, GRK6, ADCY1, ADCY7, RASGRP2, TIAM1, NCF1, STAT1, AKT2, NFKBIA, PIK3R5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P0DP23 | CALM1 | Calmodulin-1 | P51684 | CCR6 | C-C chemokine receptor type 6 | -0.734 | Q13547 | HDAC1 | Histone deacetylase 1 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | -0.803 | Q13547 | HDAC1 | Histone deacetylase 1 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | -0.719 | Q13547 | HDAC1 | Histone deacetylase 1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.736 | Q13547 | HDAC1 | Histone deacetylase 1 | P19875 | CXCL2 | C-X-C motif chemokine 2 | -0.862 | P0DP23 | CALM1 | Calmodulin-1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.729 | P0DP23 | CALM1 | Calmodulin-1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.729 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P09769 | FGR | Tyrosine-protein kinase Fgr | 0.796 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.782 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.971 | Q13547 | HDAC1 | Histone deacetylase 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.774 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P0DP23 | CALM1 | Calmodulin-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.869 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P0DP23 | CALM1 | Calmodulin-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.82 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.703 | Q13547 | HDAC1 | Histone deacetylase 1 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.864 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.704 | Q13547 | HDAC1 | Histone deacetylase 1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.716 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43250 | GRK6 | G protein-coupled receptor kinase 6 | 0.818 | P0DP23 | CALM1 | Calmodulin-1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.725 | P0DP23 | CALM1 | Calmodulin-1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.719 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P0DP23 | CALM1 | Calmodulin-1 | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | -0.788 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | -0.746 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13009 | TIAM1 | Rho guanine nucleotide exchange factor TIAM1 | 0.706 | P0DP23 | CALM1 | Calmodulin-1 | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.854 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.785 | P0DP23 | CALM1 | Calmodulin-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.783 | P0DP23 | CALM1 | Calmodulin-1 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.761 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.818 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.752 |
| Cinchocaine | hsa04064 | NF-kappa B signaling pathway | 1.67E-05 | 15 | P10415, Q13489, P51617, P14778, P01584, P29965, P19174, Q04759, P06239, O75293, Q8NHW4, P09341, P19875, Q06643, Q9NQC7 | BCL2, BIRC3, IRAK1, IL1R1, IL1B, CD40LG, PLCG1, PRKCQ, LCK, GADD45B, CCL4L2, CXCL1, CXCL2, LTB, CYLD | More | | Cinchocaine | hsa04070 | Phosphatidylinositol signaling system | 4.94E-05 | 6 | P19174, P0DP23, P23743, P48426, P27987, P17252 | PLCG1, CALM1, DGKA, PIP4K2A, ITPKB, PRKCA | More | | Cinchocaine | hsa04071 | Sphingolipid signaling pathway | 3.04E-03 | 9 | P17252, Q13510, Q13362, Q16537, Q9BX95, P04637, P10415, Q9UQC2, P01042 | PRKCA, ASAH1, PPP2R5C, PPP2R5E, SGPP1, TP53, BCL2, GAB2, KNG1 | More | | Cinchocaine | hsa04072 | Phospholipase D signaling pathway | 3.71E-04 | 14 | P31751, P42338, Q92529, P43657, P25024, P25025, P19174, P17252, Q14344, Q15438, Q08828, P51828, P23743, P00734 | AKT2, PIK3CB, SHC3, P2RY5, CXCR1, CXCR2, PLCG1, PRKCA, GNA13, PSCD1, ADCY1, ADCY7, DGKA, F2 | More | | Cinchocaine | hsa04120 | Ubiquitin mediated proteolysis | 3.44E-02 | 4 | Q14145, Q13042, P62837, Q15751 | KEAP1, CDC16, UBE2D2, HERC1 | More | | Cinchocaine | hsa04140 | Autophagy - animal | 2.58E-02 | 7 | P31751, Q7L523, Q96RR4, O75460, P10415, Q96GC9, Q8TEV9 | AKT2, RRAGA, CAMKK2, ERN1, BCL2, TMEM49, SMCR8 | More | | Cinchocaine | hsa04141 | Protein processing in endoplasmic reticulum | 2.17E-03 | 9 | P18848, P30101, O60337, P60604, P11142, P07900, P08238, Q9H173, Q9UNL2 | ATF4, PDIA3, MARH6, UBE2G2, HSPA8, HSP90AA1, HSP90AB1, SIL1, SSR3 | More | | Cinchocaine | hsa04144 | Endocytosis | 8.99E-03 | 12 | P11142, Q9H444, O43633, O75351, Q9NZZ3, Q15438, Q14161, P14784, Q96QK1, Q9UMY4, Q9Y5X3, Q9UNH7 | HSPA8, CHMP4B, CHMP2A, VPS4B, CHMP5, PSCD1, GIT2, IL2RB, VPS35, SNX12, SNX5, SNX6 | More | | Cinchocaine | hsa04145 | Phagosome | 3.87E-07 | 14 | P11215, P60709, P63261, Q15075, Q15080, P14598, Q71U36, Q13509, P68371, Q13488, P05164, O60603, P35443, P13765 | ITGAM, ACTB, ACTG1, EEA1, NCF4, NCF1, TUBA1A, TUBB3, TUBB2C, TCIRG1, MPO, TLR2, THBS4, HLA-DOB | More | | Cinchocaine | hsa04151 | PI3K-Akt signaling pathway | 6.34E-04 | 26 | P42338, P43657, O43521, P27348, P20827, P49767, Q13362, P08238, Q8WYR1, P62873, P63218, P50151, P16144, O15335, Q13751, P48551, P14784, P23458, P01568, P15336, P18848, P10415, P17252, Q16513, Q6ZUJ8, P30281 | PIK3CB, P2RY5, BCL2L11, YWHAQ, EFNA1, VEGFC, PPP2R5C, HSP90AB1, PIK3R5, GNB1, GNG5, GNG10, ITGB4, CHAD, LAMB3, IFNAR2, IL2RB, JAK1, IFNA21, ATF2, ATF4, BCL2, PRKCA, PKN2, PIK3AP1, CCND3 | More | | Cinchocaine | hsa04210 | Apoptosis | 6.18E-03 | 3 | P07384, P60709, P63261 | CAPN1, ACTB, ACTG1 | More | | Cinchocaine | hsa04213 | Longevity regulating pathway - multiple species | 4.41E-03 | 4 | P42338, Q9Y4H2, P11142, Q13547 | PIK3CB, IRS2, HSPA8, HDAC1 | More | | Cinchocaine | hsa04217 | Necroptosis | 1.49E-11 | 22 | P01375, P01568, P23458, P48023, Q13489, Q9NQC7, P42224, Q14765, P07900, P08238, P15104, P05141, P01584, P0C0S5, Q6FI13, Q99878, P10415, Q13557, Q9H444, O43633, Q9NZZ3, O75351 | TNF, IFNA21, JAK1, FASLG, BIRC3, CYLD, STAT1, STAT4, HSP90AA1, HSP90AB1, GLUL, SLC25A5, IL1B, H2AFZ, H2AC18; H2AC19, H2AC14, BCL2, CAMK2D, CHMP4B, CHMP2A, CHMP5, VPS4B | More | | Cinchocaine | hsa04261 | Adrenergic signaling in cardiomyocytes | 4.43E-06 | 11 | P09493, Q08828, P51828, P31751, P18848, Q13362, P0DP23, Q13557, P17252, P10415, P23634 | TPM1, ADCY1, ADCY7, AKT2, ATF4, PPP2R5C, CALM1, CAMK2D, PRKCA, BCL2, ATP2B4 | More | | Cinchocaine | hsa04330 | Notch signaling pathway | 3.28E-03 | 4 | Q92542, P49768, Q92830, P78504 | NCSTN, PSEN1, KAT2A, JAG1 | More | | Cinchocaine | hsa04360 | Axon guidance | 1.15E-04 | 10 | P61073, P16333, P20827, O95631, P17252, Q13557, P42338, P07332, P23528, P19174 | CXCR4, NCK1, EFNA1, NTN1, PRKCA, CAMK2D, PIK3CB, FES, CFL1, PLCG1 | More | | Cinchocaine | hsa04371 | Apelin signaling pathway | 6.50E-06 | 13 | P62873, P63218, P50151, Q8WYR1, P31751, Q08828, P51828, Q13370, Q14814, Q14344, Q13485, P84022, P0DP23 | GNB1, GNG5, GNG10, PIK3R5, AKT2, ADCY1, ADCY7, PDE3B, MEF2D, GNA13, SMAD4, SMAD3, CALM1 | More | | Cinchocaine | hsa04380 | Osteoclast differentiation | 4.18E-02 | 7 | Q9NQC7, Q9UQC2, P23458, P42224, P01584, Q15080, P14598 | CYLD, GAB2, JAK1, STAT1, IL1B, NCF4, NCF1 | More | | Cinchocaine | hsa04390 | Hippo signaling pathway | 2.80E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Cinchocaine | hsa04510 | Focal adhesion | 3.76E-02 | 7 | P16144, O75369, Q15942, P17252, Q13489, P10415, P49767 | ITGB4, FLNB, ZYX, PRKCA, BIRC3, BCL2, VEGFC | More | | Cinchocaine | hsa04520 | Adherens junction | 1.58E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Cinchocaine | hsa04530 | Tight junction | 3.88E-03 | 3 | P60709, P63261, P60660 | ACTB, ACTG1, MYL6 | More | | Cinchocaine | hsa04540 | Gap junction | 1.68E-04 | 8 | P17252, Q13509, P68371, Q08828, P51828, Q71U36, Q9NRA1, Q14643 | PRKCA, TUBB3, TUBB2C, ADCY1, ADCY7, TUBA1A, PDGFC, ITPR1 | More | | Cinchocaine | hsa04610 | Complement and coagulation cascades | 2.46E-02 | 3 | P00734, P0C0L4, P21730 | F2, C4A, C5AR1 | More | | Cinchocaine | hsa04611 | Platelet activation | 2.61E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Cinchocaine | hsa04612 | Antigen processing and presentation | 1.64E-02 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Cinchocaine | hsa04613 | Neutrophil extracellular trap formation | 9.76E-05 | 21 | P17252, P11215, O60603, P05164, P08246, Q9UM07, Q13547, Q92769, Q6FI13, P58876, Q16778, O60814, P14598, Q15080, P08311, O75015, P21730, P21462, P63261, O43315, Q16539 | PRKCA, ITGAM, TLR2, MPO, ELA2, PADI4, HDAC1, HDAC2, H2AC18; H2AC19, H2BC5, HIST2H2BE, H2BC12, NCF1, NCF4, CTSG, FCGR3B, C5AR1, FPR1, ACTG1, AQP9, MAPK14 | More | | Cinchocaine | hsa04620 | Toll-like receptor signaling pathway | 1.33E-02 | 5 | P51617, P01568, P31751, P42224, Q8NHW4 | IRAK1, IFNA21, AKT2, STAT1, CCL4L2 | More | | Cinchocaine | hsa04621 | NOD-like receptor signaling pathway | 3.16E-02 | 9 | P01584, P08238, P23458, P42224, P01568, Q9H3M7, Q13489, P43490, P10415 | IL1B, HSP90AB1, JAK1, STAT1, IFNA21, TXNIP, BIRC3, PBEF1, BCL2 | More | | Cinchocaine | hsa04623 | Cytosolic DNA-sensing pathway | 2.89E-03 | 3 | P01568, P25963, Q8NHW4 | IFNA21, NFKBIA, CCL4L2 | More | | Cinchocaine | hsa04625 | C-type lectin receptor signaling pathway | 4.80E-02 | 6 | Q9ULY5, P20749, Q14643, P01375, Q13191, Q16539 | CLEC4E, BCL3, ITPR1, TNF, CBLB, MAPK14 | More | | Cinchocaine | hsa04630 | JAK-STAT signaling pathway | 1.16E-02 | 8 | P31751, P10415, P42224, P23458, P14784, P16871, Q13651, P01568 | AKT2, BCL2, STAT1, JAK1, IL2RB, IL7R, IL10RA, IFNA21 | More | | Cinchocaine | hsa04640 | Hematopoietic cell lineage | 5.48E-05 | 15 | P13612, P08514, P21926, P14778, P27930, P11215, P15144, P11836, P25063, P07766, P09693, P01732, P09564, P13765, P01375 | ITGA4, ITGA2B, CD9, IL1R1, IL1R2, ITGAM, ANPEP, MS4A1, CD24, CD3E, CD3G, CD8A, CD7, HLA-DOB, TNF | More | | Cinchocaine | hsa04650 | Natural killer cell mediated cytotoxicity | 2.05E-04 | 13 | P19174, P01375, P78314, P06239, O60880, P20963, P42338, Q13241, P26718, O14931, O75015, P26717, P26715 | PLCG1, TNF, SH3BP2, LCK, SH2D1A, CD247, PIK3CB, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC1 | More | | Cinchocaine | hsa04657 | IL-17 signaling pathway | 1.77E-03 | 9 | P07900, O00463, Q16539, P49841, P09341, P14780, P80188, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF, IL1B | More | | Cinchocaine | hsa04658 | Th1 and Th2 cell differentiation | 8.90E-06 | 13 | Q04759, P07766, P20963, P09693, Q16539, P19174, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | | Cinchocaine | hsa04659 | Th17 cell differentiation | 5.62E-07 | 17 | P25963, Q04759, Q16539, P19174, P06239, P42224, P14784, P13765, P14778, Q9UL17, P23771, P84022, Q13485, P08238, P07766, P09693, P20963 | NFKBIA, PRKCQ, MAPK14, PLCG1, LCK, STAT1, IL2RB, HLA-DOB, IL1R1, TBX21, GATA3, SMAD3, SMAD4, HSP90AB1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.818 | Q13547 | HDAC1 | Histone deacetylase 1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.723 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q04759 | PRKCQ | Protein kinase C theta type | -0.762 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.833 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.869 | Q13547 | HDAC1 | Histone deacetylase 1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.7 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | Q13547 | HDAC1 | Histone deacetylase 1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.811 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.783 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.717 | Q13547 | HDAC1 | Histone deacetylase 1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.816 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.73 | Q13547 | HDAC1 | Histone deacetylase 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.854 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.762 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.764 | Q13547 | HDAC1 | Histone deacetylase 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.817 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.861 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.767 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | -0.77 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 1 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | Q13547 | HDAC1 | Histone deacetylase 1 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.802 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.838 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.815 | Q13547 | HDAC1 | Histone deacetylase 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.87 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.77 |
| Cinchocaine | hsa04660 | T cell receptor signaling pathway | 1.06E-04 | 14 | P01375, Q04759, P42338, O95267, Q08881, P19174, P07766, P20963, P09693, P01732, Q13191, P06239, Q16539, P49841 | TNF, PRKCQ, PIK3CB, RASGRP1, ITK, PLCG1, CD3E, CD247, CD3G, CD8A, CBLB, LCK, MAPK14, GSK3B | More | | Cinchocaine | hsa04662 | B cell receptor signaling pathway | 5.02E-04 | 8 | P25963, P42338, P20023, P60033, P13164, P07948, P21854, Q8N149 | NFKBIA, PIK3CB, CR2, CD81, IFITM1, LYN, CD72, LILRA2 | More | | Cinchocaine | hsa04664 | Fc epsilon RI signaling pathway | 5.14E-04 | 5 | P04141, P42338, P07948, P19174, P09917 | CSF2, PIK3CB, LYN, PLCG1, ALOX5 | More | | Cinchocaine | hsa04666 | Fc gamma R-mediated phagocytosis | 1.15E-03 | 8 | P08575, P19174, P23528, P49006, P06396, Q9UQC2, P14598, P17252 | PTPRC, PLCG1, CFL1, MARCKSL1, GSN, GAB2, NCF1, PRKCA | More | | Cinchocaine | hsa04670 | Leukocyte transendothelial migration | 4.07E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Cinchocaine | hsa04713 | Circadian entrainment | 4.05E-06 | 9 | O15399, P0DP23, Q13557, P17252, P62873, P63218, P50151, Q08828, P51828 | GRIN2D, CALM1, CAMK2D, PRKCA, GNB1, GNG5, GNG10, ADCY1, ADCY7 | More | | Cinchocaine | hsa04714 | Thermogenesis | 3.64E-04 | 4 | P15336, P60709, P63261, P36542 | ATF2, ACTB, ACTG1, ATP5C1 | More | | Cinchocaine | hsa04720 | Long-term potentiation | 3.26E-03 | 6 | P17252, Q13557, P0DP23, P18848, O15399, Q08828 | PRKCA, CAMK2D, CALM1, ATF4, GRIN2D, ADCY1 | More | | Cinchocaine | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Cinchocaine | hsa04724 | Glutamatergic synapse | 2.96E-04 | 9 | P48058, O15399, Q08828, P51828, P17252, P62873, P63218, P50151, P15104 | GRIA4, GRIN2D, ADCY1, ADCY7, PRKCA, GNB1, GNG5, GNG10, GLUL | More | | Cinchocaine | hsa04725 | Cholinergic synapse | 4.42E-04 | 8 | Q08828, P51828, P17252, P62873, P18848, Q13557, P31751, P10415 | ADCY1, ADCY7, PRKCA, GNB1, ATF4, CAMK2D, AKT2, BCL2 | More | | Cinchocaine | hsa04726 | Serotonergic synapse | 3.80E-02 | 4 | P62873, P63218, P50151, P09917 | GNB1, GNG5, GNG10, ALOX5 | More | | Cinchocaine | hsa04727 | GABAergic synapse | 9.05E-04 | 8 | Q08828, P51828, P62873, P63218, P50151, P15104, P46459, P17252 | ADCY1, ADCY7, GNB1, GNG5, GNG10, GLUL, NSF, PRKCA | More | | Cinchocaine | hsa04730 | Long-term depression | 6.53E-03 | 2 | Q14344, P07948 | GNA13, LYN | More | | Cinchocaine | hsa04740 | Olfactory transduction | 2.61E-02 | 3 | P62873, Q13557, P0DP23 | GNB1, CAMK2D, CALM1 | More | | Cinchocaine | hsa04744 | Phototransduction | 1.82E-07 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Cinchocaine | hsa04750 | Inflammatory mediator regulation of TRP channels | 1.34E-06 | 12 | P14778, P01584, Q08828, P51828, Q13557, P19174, P42338, P17252, P24723, Q04759, P0DP23, P01042 | IL1R1, IL1B, ADCY1, ADCY7, CAMK2D, PLCG1, PIK3CB, PRKCA, PRKCH, PRKCQ, CALM1, KNG1 | More | | Cinchocaine | hsa04911 | Insulin secretion | 3.47E-02 | 4 | Q08828, P17252, P18848, Q13557 | ADCY1, PRKCA, ATF4, CAMK2D | More | | Cinchocaine | hsa04912 | GnRH signaling pathway | 4.76E-03 | 9 | P17252, Q08828, P18848, Q13557, Q16539, Q9Y6R4, Q14643, P0DP23, P22694 | PRKCA, ADCY1, ATF4, CAMK2D, MAPK14, MAP3K4, ITPR1, CALM1, PRKACB | More | | Cinchocaine | hsa04914 | Progesterone-mediated oocyte maturation | 3.26E-02 | 6 | Q08828, P51828, P31751, Q13370, Q9UJX4, P08238 | ADCY1, ADCY7, AKT2, PDE3B, ANAPC5, HSP90AB1 | More | | Cinchocaine | hsa04915 | Estrogen signaling pathway | 3.28E-03 | 9 | P18848, Q08828, P51828, P31751, P08238, P11142, P0DP23, Q15788, P10415 | ATF4, ADCY1, ADCY7, AKT2, HSP90AB1, HSPA8, CALM1, NCOA1, BCL2 | More | | Cinchocaine | hsa04919 | Thyroid hormone signaling pathway | 3.20E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Cinchocaine | hsa04920 | Adipocytokine signaling pathway | 4.72E-02 | 4 | P33121, Q04759, Q9Y4H2, P01375 | ACSL1, PRKCQ, IRS2, TNF | More | | Cinchocaine | hsa04921 | Oxytocin signaling pathway | 1.77E-03 | 3 | P60660, P60709, P63261 | MYL6, ACTB, ACTG1 | More | | Cinchocaine | hsa04923 | Regulation of lipolysis in adipocytes | 1.20E-03 | 7 | Q08828, P51828, P07550, Q13370, P42338, Q9Y4H2, P31751 | ADCY1, ADCY7, ADRB2, PDE3B, PIK3CB, IRS2, AKT2 | More | | Cinchocaine | hsa04925 | Aldosterone synthesis and secretion | 6.45E-04 | 7 | P18848, Q08828, P51828, P0DP23, P17252, Q13557, P23634 | ATF4, ADCY1, ADCY7, CALM1, PRKCA, CAMK2D, ATP2B4 | More | | Cinchocaine | hsa04932 | Non-alcoholic fatty liver disease | 6.43E-04 | 7 | P01375, P49841, P18848, P48023, P01584, P13073, O15239 | TNF, GSK3B, ATF4, FASLG, IL1B, COX4I1, NDUFA1 | More | | Cinchocaine | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.38E-07 | 10 | P84022, Q13485, P01584, P42224, P10415, P31751, P42338, P49767, P17252, P19174 | SMAD3, SMAD4, IL1B, STAT1, BCL2, AKT2, PIK3CB, VEGFC, PRKCA, PLCG1 | More | | Cinchocaine | hsa04935 | Growth hormone synthesis, secretion and action | 3.93E-02 | 6 | P19174, Q08828, P51828, P17252, P31751, P42224 | PLCG1, ADCY1, ADCY7, PRKCA, AKT2, STAT1 | More | | Cinchocaine | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Cinchocaine | hsa04960 | Aldosterone-regulated sodium reabsorption | 4.38E-02 | 1 | P48048 | KCNJ1 | More | | Cinchocaine | hsa04970 | Salivary secretion | 1.35E-03 | 5 | Q08828, P51828, P23634, P17252, P0DP23 | ADCY1, ADCY7, ATP2B4, PRKCA, CALM1 | More | | Cinchocaine | hsa04971 | Gastric acid secretion | 1.02E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Cinchocaine | hsa04972 | Pancreatic secretion | 1.41E-04 | 7 | Q14643, P20020, P23634, P17252, Q08828, P51828, P62491 | ITPR1, ATP2B1, ATP2B4, PRKCA, ADCY1, ADCY7, RAB11A | More | | Cinchocaine | hsa04973 | Carbohydrate digestion and absorption | 1.29E-02 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Cinchocaine | hsa05012 | Parkinson disease | 2.58E-03 | 11 | O15239, P13073, P05141, P60604, P18848, P19174, P0DP23, Q13557, Q71U36, Q13509, P68371 | NDUFA1, COX4I1, SLC25A5, UBE2G2, ATF4, PLCG1, CALM1, CAMK2D, TUBA1A, TUBB3, TUBB2C | More | | Cinchocaine | hsa05014 | Amyotrophic lateral sclerosis | 2.98E-02 | 3 | P36542, P60709, P63261 | ATP5C1, ACTB, ACTG1 | More | | Cinchocaine | hsa05016 | Huntington disease | 3.21E-02 | 5 | O15239, P13073, P30876, P62487, P05141 | NDUFA1, COX4I1, POLR2B, POLR2G, SLC25A5 | More | | Cinchocaine | hsa05017 | Spinocerebellar ataxia | 3.80E-03 | 8 | P17252, O75460, Q8TB72, O15399, P31751, P28070, P43686, O00232 | PRKCA, ERN1, PUM2, GRIN2D, AKT2, PSMB4, PSMC4, PSMD12 | More | | Cinchocaine | hsa05020 | Prion disease | 3.37E-03 | 7 | P13591, P01584, P11142, O15239, P13073, P18848, P05141 | NCAM1, IL1B, HSPA8, NDUFA1, COX4I1, ATF4, SLC25A5 | More | | Cinchocaine | hsa05022 | Pathways of neurodegeneration - multiple diseases | 3.80E-02 | 6 | O15239, P13073, P18848, P05141, P01584, Q13557 | NDUFA1, COX4I1, ATF4, SLC25A5, IL1B, CAMK2D | More | | Cinchocaine | hsa05031 | Amphetamine addiction | 2.85E-02 | 5 | O15399, P0DP23, Q13557, P18848, P17252 | GRIN2D, CALM1, CAMK2D, ATF4, PRKCA | More | | Cinchocaine | hsa05032 | Morphine addiction | 2.71E-03 | 7 | Q08828, P51828, P62873, P63218, P50151, Q13370, P17252 | ADCY1, ADCY7, GNB1, GNG5, GNG10, PDE3B, PRKCA | More | | Cinchocaine | hsa05034 | Alcoholism | 2.10E-03 | 4 | Q13547, P58876, Q16778, O60814 | HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | | Cinchocaine | hsa05100 | Bacterial invasion of epithelial cells | 1.02E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Cinchocaine | hsa05110 | Vibrio cholerae infection | 3.95E-03 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Cinchocaine | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 7.88E-05 | 8 | P25963, Q13488, P09341, P19875, P19174, P25024, P25025, P07948 | NFKBIA, TCIRG1, CXCL1, CXCL2, PLCG1, CXCR1, CXCR2, LYN | More | | Cinchocaine | hsa05130 | Pathogenic Escherichia coli infection | 3.19E-02 | 6 | Q71U36, P16333, Q13509, P68371, Q14344, P25963 | TUBA1A, NCK1, TUBB3, TUBB2C, GNA13, NFKBIA | More | | Cinchocaine | hsa05131 | Shigellosis | 1.91E-02 | 3 | P60709, P63261, P07384 | ACTB, ACTG1, CAPN1 | More | | Cinchocaine | hsa05132 | Salmonella infection | 4.12E-06 | 19 | P51617, P01584, P25963, P08238, Q9UJU2, P63261, Q96RF0, Q13489, P10415, P08575, O75369, O60603, Q9BQS8, Q13561, Q71U36, Q13509, P68371, P49754, Q9NP90 | IRAK1, IL1B, NFKBIA, HSP90AB1, LEF1, ACTG1, SNAG1, BIRC3, BCL2, PTPRC, FLNB, TLR2, FYCO1, DCTN2, TUBA1A, TUBB3, TUBB2C, VPS41, RAB9B | More | | Cinchocaine | hsa05133 | Pertussis | 3.94E-04 | 5 | P0DP23, P01584, P23528, P09871, P51617 | CALM1, IL1B, CFL1, C1S, IRAK1 | More | | Cinchocaine | hsa05134 | Legionellosis | 8.66E-05 | 7 | P01584, P25963, P11215, P68104, P11142, P09341, P19875 | IL1B, NFKBIA, ITGAM, EEF1A1, HSPA8, CXCL1, CXCL2 | More | | Cinchocaine | hsa05135 | Yersinia infection | 3.88E-03 | 3 | P60709, P63261, Q16513 | ACTB, ACTG1, PKN2 | More | | Cinchocaine | hsa05140 | Leishmaniasis | 1.87E-05 | 13 | P13612, O75015, P14598, P11215, P42224, P13765, O60603, P25963, P01375, P29350, P49006, Q16539, Q15080 | ITGA4, FCGR3B, NCF1, ITGAM, STAT1, HLA-DOB, TLR2, NFKBIA, TNF, PTPN6, MARCKSL1, MAPK14, NCF4 | More | | Cinchocaine | hsa05143 | African trypanosomiasis | 3.56E-03 | 5 | P01375, P01584, P48023, P17252, P01042 | TNF, IL1B, FASLG, PRKCA, KNG1 | More | | Cinchocaine | hsa05144 | Malaria | 1.56E-03 | 8 | P60033, P69905, P68871, O60603, P01375, P35443, P10145, P26718 | CD81, HBA2, HBB, TLR2, TNF, THBS4, IL8, KLRK1 | More | | Cinchocaine | hsa05145 | Toxoplasmosis | 5.28E-05 | 9 | P51617, P10415, Q13489, P23458, P42224, P31751, P11142, P29965, Q13651 | IRAK1, BCL2, BIRC3, JAK1, STAT1, AKT2, HSPA8, CD40LG, IL10RA | More | | Cinchocaine | hsa05146 | Amoebiasis | 8.90E-06 | 12 | P09341, P19875, P14778, P27930, P01375, O60603, P42338, P11215, P05089, P22694, P12814, P08311 | CXCL1, CXCL2, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ITGAM, ARG1, PRKACB, ACTN1, CTSG | More | | Cinchocaine | hsa05150 | Staphylococcus aureus infection | 4.66E-02 | 4 | P0C0L4, P21730, P21462, P13646 | C4A, C5AR1, FPR1, KRT13 | More | | Cinchocaine | hsa05160 | Hepatitis C | 1.27E-02 | 4 | P60033, P49841, P01375, P48023 | CD81, GSK3B, TNF, FASLG | More | | Cinchocaine | hsa05161 | Hepatitis B | 1.31E-04 | 10 | P17252, P18848, P23458, Q13485, P31751, P10415, P27348, P01568, P42224, P51617 | PRKCA, ATF4, JAK1, SMAD4, AKT2, BCL2, YWHAQ, IFNA21, STAT1, IRAK1 | More | | Cinchocaine | hsa05162 | Measles | 2.45E-05 | 10 | P51617, P01568, P23458, P42224, P14784, P31751, P11142, P01584, Q9NP90, P10415 | IRAK1, IFNA21, JAK1, STAT1, IL2RB, AKT2, HSPA8, IL1B, RAB9B, BCL2 | More | | Cinchocaine | hsa05163 | Human cytomegalovirus infection | 5.44E-05 | 19 | P31751, P25963, P62873, P63218, P50151, P0DP23, Q14344, Q8NHW4, Q08828, P51828, P23458, P01584, P61073, P17252, Q13651, P18848, P30101, P61769, P01568 | AKT2, NFKBIA, GNB1, GNG5, GNG10, CALM1, GNA13, CCL4L2, ADCY1, ADCY7, JAK1, IL1B, CXCR4, PRKCA, IL10RA, ATF4, PDIA3, B2M, IFNA21 | More | | Cinchocaine | hsa05164 | Influenza A | 7.10E-03 | 3 | P48551, P60709, P63261 | IFNAR2, ACTB, ACTG1 | More | | Cinchocaine | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 8.62E-05 | 10 | P01568, P42224, P25963, P62873, P63218, P50151, P19174, P07948, P04141, P0DP23 | IFNA21, STAT1, NFKBIA, GNB1, GNG5, GNG10, PLCG1, LYN, CSF2, CALM1 | More | | Cinchocaine | hsa05168 | Herpes simplex virus 1 infection | 3.41E-06 | 21 | P25963, P01568, P01584, Q9UBU9, P23458, P42224, Q07955, Q01130, Q13243, Q13489, P51617, P30101, P61769, P31751, Q13398, Q6P280, Q03923, O75820, Q9UDV6, P10415, Q14232 | NFKBIA, IFNA21, IL1B, NXF1, JAK1, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, IRAK1, PDIA3, B2M, AKT2, ZNF211, ZNF529, ZNF85, ZNF189, ZNF212, BCL2, EIF2B1 | More | | Cinchocaine | hsa05170 | Human immunodeficiency virus 1 infection | 2.01E-06 | 16 | P31751, P62873, P63218, P50151, P0DP23, P61073, P17252, P30101, P61769, P01568, P51617, P25963, P19174, P23528, P10415, Q9Y6Q5 | AKT2, GNB1, GNG5, GNG10, CALM1, CXCR4, PRKCA, PDIA3, B2M, IFNA21, IRAK1, NFKBIA, PLCG1, CFL1, BCL2, AP1M2 | More | | Cinchocaine | hsa05171 | Coronavirus disease - COVID-19 | 9.72E-03 | 7 | P01584, P62753, P25398, P36578, P32969, P18077, P62829 | IL1B, RPS6, RPS12, RPL4, RPL9, RPL35A, RPL23 | More | | Cinchocaine | hsa05200 | Pathways in cancer | 2.33E-12 | 40 | Q13751, P42338, P23458, P08238, P42224, P25963, P19174, Q15311, P17252, P43246, P84022, Q13485, P20585, Q13547, P14923, P30281, P10415, Q13489, P49767, P31751, P43657, Q08828, P51828, P62873, P63218, P50151, Q14344, Q7LDG7, P61073, P78417, O75293, Q15788, P0DP23, Q13557, O43521, P01568, P14784, P16871, P00734, P01042 | LAMB3, PIK3CB, JAK1, HSP90AB1, STAT1, NFKBIA, PLCG1, RALBP1, PRKCA, MSH2, SMAD3, SMAD4, MSH3, HDAC1, JUP, CCND3, BCL2, BIRC3, VEGFC, AKT2, P2RY5, ADCY1, ADCY7, GNB1, GNG5, GNG10, GNA13, RASGRP2, CXCR4, GSTO1, GADD45B, NCOA1, CALM1, CAMK2D, BCL2L11, IFNA21, IL2RB, IL7R, F2, KNG1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P0DP23 | CALM1 | Calmodulin-1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.822 | P0DP24 | CALM2 | Calmodulin-2 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.738 | P0DP23 | CALM1 | Calmodulin-1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 1 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P0DP25 | CALM3 | Calmodulin-3 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.775 | P0DP23 | CALM1 | Calmodulin-1 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.783 | P0DP25 | CALM3 | Calmodulin-3 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P0DP24 | CALM2 | Calmodulin-2 | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.775 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.818 | P0DP23 | CALM1 | Calmodulin-1 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.869 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P0DP25 | CALM3 | Calmodulin-3 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP24 | CALM2 | Calmodulin-2 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.744 | P0DP23 | CALM1 | Calmodulin-1 | Q15311 | RALBP1 | RalA-binding protein 1 | 0.858 | P0DP23 | CALM1 | Calmodulin-1 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP25 | CALM3 | Calmodulin-3 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP24 | CALM2 | Calmodulin-2 | P17252 | PRKCA | Protein kinase C alpha type | -0.776 | P0DP23 | CALM1 | Calmodulin-1 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.816 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.811 | P0DP25 | CALM3 | Calmodulin-3 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P0DP24 | CALM2 | Calmodulin-2 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.944 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | -0.77 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P0DP23 | CALM1 | Calmodulin-1 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P0DP25 | CALM3 | Calmodulin-3 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P0DP24 | CALM2 | Calmodulin-2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | 0.777 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P20585 | MSH3 | DNA mismatch repair protein Msh3 | 0.825 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.754 | P0DP23 | CALM1 | Calmodulin-1 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP25 | CALM3 | Calmodulin-3 | P14923 | JUP | Junction plakoglobin | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P14923 | JUP | Junction plakoglobin | -0.852 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 | P0DP23 | CALM1 | Calmodulin-1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP25 | CALM3 | Calmodulin-3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP24 | CALM2 | Calmodulin-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | -0.772 | P0DP23 | CALM1 | Calmodulin-1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP25 | CALM3 | Calmodulin-3 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP24 | CALM2 | Calmodulin-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.8 | P0DP23 | CALM1 | Calmodulin-1 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P0DP25 | CALM3 | Calmodulin-3 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP24 | CALM2 | Calmodulin-2 | P49767 | VEGFC | Vascular endothelial growth factor C | -0.84 | P0DP23 | CALM1 | Calmodulin-1 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.761 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P0DP23 | CALM1 | Calmodulin-1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.725 | P0DP24 | CALM2 | Calmodulin-2 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.711 | P0DP23 | CALM1 | Calmodulin-1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.719 | P0DP23 | CALM1 | Calmodulin-1 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.82 | P0DP25 | CALM3 | Calmodulin-3 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P0DP24 | CALM2 | Calmodulin-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | 0.853 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | -0.703 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | -0.704 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | -0.756 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P0DP24 | CALM2 | Calmodulin-2 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.759 | P0DP23 | CALM1 | Calmodulin-1 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP25 | CALM3 | Calmodulin-3 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP24 | CALM2 | Calmodulin-2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | -0.804 | P0DP23 | CALM1 | Calmodulin-1 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.742 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.731 | P0DP25 | CALM3 | Calmodulin-3 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP24 | CALM2 | Calmodulin-2 | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.853 | P0DP24 | CALM2 | Calmodulin-2 | Q15788 | NCOA1 | Nuclear receptor coactivator 1 | 0.731 | P0DP23 | CALM1 | Calmodulin-1 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P0DP23 | CALM1 | Calmodulin-1 | 0.775 | P0DP25 | CALM3 | Calmodulin-3 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | P0DP23 | CALM1 | Calmodulin-1 | 1 | P0DP24 | CALM2 | Calmodulin-2 | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.786 | P0DP24 | CALM2 | Calmodulin-2 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.75 | P0DP23 | CALM1 | Calmodulin-1 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P01568 | IFNA21 | Interferon alpha-21 | -0.733 | P0DP25 | CALM3 | Calmodulin-3 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP24 | CALM2 | Calmodulin-2 | P01568 | IFNA21 | Interferon alpha-21 | -0.852 | P0DP23 | CALM1 | Calmodulin-1 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.717 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P0DP25 | CALM3 | Calmodulin-3 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP24 | CALM2 | Calmodulin-2 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.801 | P0DP23 | CALM1 | Calmodulin-1 | P16871 | IL7R | Interleukin-7 receptor subunit alpha | 0.718 | P0DP23 | CALM1 | Calmodulin-1 | P00734 | F2 | Prothrombin | -0.738 | P0DP23 | CALM1 | Calmodulin-1 | P01042 | KNG1 | Kininogen-1 | -0.71 | P0DP25 | CALM3 | Calmodulin-3 | P01042 | KNG1 | Kininogen-1 | -0.71 | P0DP24 | CALM2 | Calmodulin-2 | P01042 | KNG1 | Kininogen-1 | -0.71 |
| Cinchocaine | hsa05202 | Transcriptional misregulation in cancer | 7.93E-06 | 22 | Q12778, Q15532, P41732, P14780, P27930, P14923, Q16548, P11215, Q13489, Q13077, O15550, P04637, P35226, P05164, P12838, P08246, Q9C0K0, P41182, Q13547, Q92769, P12980, P24522 | FOXO1, SS18, TSPAN7, MMP9, IL1R2, JUP, BCL2A1, ITGAM, BIRC3, TRAF1, UTX, TP53, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, HDAC1, HDAC2, LYL1, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q12778 | FOXO1 | Forkhead box protein O1 | 0.714 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q15532 | SS18 | Protein SSXT | 0.893 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P41732 | TSPAN7 | Tetraspanin-7 | -0.834 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P41732 | TSPAN7 | Tetraspanin-7 | 0.703 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.72 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.942 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.711 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.924 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P14923 | JUP | Junction plakoglobin | 0.914 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.913 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | P11215 | ITGAM | Integrin alpha-M | 0.706 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.71 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.712 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | O15550 | UTX | Lysine-specific demethylase 6A | -0.808 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P04637 | TP53 | Cellular tumor antigen p53 | 0.753 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.778 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.778 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P05164 | MPO | Myeloperoxidase | -0.754 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P05164 | MPO | Myeloperoxidase | 0.711 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P12838 | DEFA4 | Neutrophil defensin 4 | 0.767 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P08246 | ELA2 | Neutrophil elastase | -0.833 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P08246 | ELA2 | Neutrophil elastase | 0.703 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.741 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.765 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.9 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | Q13547 | HDAC1 | Histone deacetylase 1 | -0.711 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q13547 | HDAC1 | Histone deacetylase 1 | -0.742 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | Q92769 | HDAC2 | Histone deacetylase 2 | -0.746 | O15245 | SLC22A1 | Solute carrier family 22 member 1 | P12980 | LYL1 | Protein lyl-1 | 0.806 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P12980 | LYL1 | Protein lyl-1 | 0.782 | Q13093 | PLA2G7 | Platelet-activating factor acetylhydrolase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.768 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.801 |
| Cinchocaine | hsa05203 | Viral carcinogenesis | 6.44E-03 | 4 | Q13547, P58876, Q16778, O60814 | HDAC1, H2BC5, HIST2H2BE, H2BC12 | More | | Cinchocaine | hsa05204 | Chemical carcinogenesis | 3.70E-03 | 3 | P00325, P78417, P33260 | ADH1B, GSTO1, CYP2C18 | More | | Cinchocaine | hsa05205 | Proteoglycans in cancer | 2.66E-02 | 8 | Q14643, P63261, P04637, P14780, P17252, O60603, Q13635, P08962 | ITPR1, ACTG1, TP53, MMP9, PRKCA, TLR2, PTCH1, CD63 | More | | Cinchocaine | hsa05206 | MicroRNAs in cancer | 4.07E-02 | 2 | P15311, P63279 | VIL2, UBE2I | More | | Cinchocaine | hsa05212 | Pancreatic cancer | 8.24E-05 | 8 | P42338, P31751, Q15311, P23458, P42224, P84022, Q13485, O75293 | PIK3CB, AKT2, RALBP1, JAK1, STAT1, SMAD3, SMAD4, GADD45B | More | | Cinchocaine | hsa05214 | Glioma | 2.48E-06 | 6 | P0DP23, Q13557, P17252, P31751, P19174, O75293 | CALM1, CAMK2D, PRKCA, AKT2, PLCG1, GADD45B | More | | Cinchocaine | hsa05216 | Thyroid cancer | 3.59E-02 | 3 | Q9UJU2, P04637, P24522 | LEF1, TP53, GADD45A | More | | Cinchocaine | hsa05217 | Basal cell carcinoma | 1.46E-02 | 4 | Q13635, Q9UJU2, P04637, P24522 | PTCH1, LEF1, TP53, GADD45A | More | | Cinchocaine | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Cinchocaine | hsa05225 | Hepatocellular carcinoma | 1.85E-03 | 4 | Q92529, P51531, P60709, P63261 | SHC3, SMARCA2, ACTB, ACTG1 | More | | Cinchocaine | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 8.27E-03 | 6 | P42338, P19174, P07766, P20963, P06239, Q04759 | PIK3CB, PLCG1, CD3E, CD247, LCK, PRKCQ | More | | Cinchocaine | hsa05321 | Inflammatory bowel disease | 2.22E-03 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Cinchocaine | hsa05322 | Systemic lupus erythematosus | 1.18E-02 | 3 | P58876, Q16778, O60814 | H2BC5, HIST2H2BE, H2BC12 | More | | Cinchocaine | hsa05323 | Rheumatoid arthritis | 3.53E-02 | 4 | P13765, P10747, P09341, O60603 | HLA-DOB, CD28, CXCL1, TLR2 | More | | Cinchocaine | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Cinchocaine | hsa05332 | Graft-versus-host disease | 3.34E-03 | 5 | P13765, P48023, P01375, P26715, Q13241 | HLA-DOB, FASLG, TNF, KLRC1, KLRD1 | More | | Cinchocaine | hsa05340 | Primary immunodeficiency | 2.68E-02 | 2 | P11912, P07766 | CD79A, CD3E | More | | Cinchocaine | hsa05410 | Hypertrophic cardiomyopathy | 1.02E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Cinchocaine | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 8.96E-03 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Cinchocaine | hsa05414 | Dilated cardiomyopathy | 1.73E-02 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Cinchocaine | hsa05415 | Diabetic cardiomyopathy | 2.87E-02 | 4 | P05141, O15239, P13073, Q13557 | SLC25A5, NDUFA1, COX4I1, CAMK2D | More | | Cinchocaine | hsa05416 | Viral myocarditis | 8.96E-03 | 2 | P60709, P63261 | ACTB, ACTG1 | More | | Cinchocaine | hsa05418 | Fluid shear stress and atherosclerosis | 6.88E-04 | 10 | P14598, P78417, P14780, P60709, P63261, P04637, P10415, P0DP23, P08238, Q92974 | NCF1, GSTO1, MMP9, ACTB, ACTG1, TP53, BCL2, CALM1, HSP90AB1, ARHGEF2 | More | | |